Camurus AB (CAMRF)
64.00
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
Camurus EPS Diluted (Quarterly) : 0.432 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.432 |
| March 31, 2026 | 0.263 |
| December 31, 2025 | 0.1778 |
| September 30, 2025 | 0.3356 |
| June 30, 2025 | 0.4225 |
| March 31, 2025 | 0.3084 |
| December 31, 2024 | 0.2275 |
| September 30, 2024 | 0.2071 |
| June 30, 2024 | 0.1166 |
| March 31, 2024 | 0.1267 |
| December 31, 2023 | -0.0257 |
| September 30, 2023 | 0.139 |
| June 30, 2023 | 0.4974 |
| March 31, 2023 | 0.0979 |
| December 31, 2022 | 0.0212 |
| September 30, 2022 | 0.0575 |
| June 30, 2022 | 0.0147 |
| March 31, 2022 | -0.0015 |
| December 31, 2021 | -0.0289 |
| September 30, 2021 | -0.0131 |
| June 30, 2021 | -0.1058 |
| March 31, 2021 | -0.048 |
| December 31, 2020 | -0.1412 |
| September 30, 2020 | -0.0427 |
| Date | Value |
|---|---|
| June 30, 2020 | -0.0399 |
| March 31, 2020 | -0.1231 |
| December 31, 2019 | -0.1524 |
| September 30, 2019 | -0.1364 |
| June 30, 2019 | -0.1933 |
| March 31, 2019 | -0.1634 |
| December 31, 2018 | -0.2298 |
| September 30, 2018 | -0.1167 |
| June 30, 2018 | -0.1909 |
| March 31, 2018 | -0.1095 |
| December 31, 2017 | -0.1541 |
| September 30, 2017 | -0.1575 |
| June 30, 2017 | -0.128 |
| March 31, 2017 | -0.1108 |
| December 31, 2016 | -0.0758 |
| September 30, 2016 | -0.0376 |
| June 30, 2016 | -0.0613 |
| March 31, 2016 | -0.0563 |
| December 31, 2015 | -0.1131 |
| September 30, 2015 | -0.3895 |
| June 30, 2015 | -1.988 |
| March 31, 2015 | 0.1779 |
| December 31, 2014 | 0.3659 |
| September 30, 2014 | -0.0356 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Orexo AB | -0.3052 |
| Swedencare AB | 0.0158 |
| Moberg Pharma AB | -0.0075 |
| Infant Bacterial Therapeutics AB | -0.1863 |
| Eli Lilly & Co. | 7.939 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 25.72M |
| Revenue (Quarterly) | 74.97M |
| Total Expenses (Quarterly) | 49.26M |
| Enterprise Value | 3.399B |
| Gross Profit Margin (Quarterly) | 92.70% |
| Profit Margin (Quarterly) | 34.30% |
| Earnings Yield | 1.89% |
| Operating Earnings Yield | 2.33% |
| Normalized Earnings Yield | 1.888 |